New Alzheimer’s blood test may tell when symptoms are around the corner
A novel biomarker beats the leading diagnostic blood test at predicting disease progression.
A novel biomarker beats the leading diagnostic blood test at predicting disease progression.
Data from more than 747,000 participants is now available to scientists, powering next-generation discoveries in precision medicine.
With neuronal data, AI models predicted grammar, meaning, and context of spoken sentences.
NIH-supported, long-term clinical trial found no difference between metformin and placebo.
New office will coordinate efforts to develop, validate and scale animal-free research models.
The Center ensures NIH grant applications receive fair, independent, expert, and timely reviews.
A panel of proteins could help match ideal candidates with preventative trials.
Dr. Aklin is expected to begin her permanent role as the NINR director on July 26, 2026.
NIH-supported findings identify a new aspect of human brain aging that may contribute to age-related cognitive decline and dementia risk.
NIH-funded, AI-powered analysis of interviews suggests that a youth’s framing of stressful events is a strong indicator of risk for future disorders.